BACKGROUND: Stroke in the young has not been thoroughly investigated with most previous studies based on a small number of patients from single centers. Furthermore, recent reports indicate that Fabry disease may be a significant cause for young stroke. The primary aim of our study was to determine the prevalence of Fabry disease in young stroke patients, while the secondary aim was to describe patterns of stroke in young patients. METHODS: We initiated the Stroke in Young Fabry Patients (sifap1) study as a multinational prospective European study of stroke patients aged 18-55 years and collected a broad range of clinical, laboratory, and radiological data using stringent standardized methods. All patients were tested for Fabry disease and blood was stored for future genetic testing. RESULTS: We managed to enroll 5,024 eligible young stroke patients in 15 countries and 47 centers across Europe between April 2007 and January 2010. The median number of patients included per center was 98 with a range between 8 and 315. The average duration of patient recruitment per center was 22 months, ranging between 5 and 33 months. The database was closed in July 2010. This paper describes protocol and methodology of the sifap1 study. CONCLUSION: The sifap1 study included the largest series of young stroke patients so far and will allow for analyses on a large number of aspects of stroke in the young.
BACKGROUND:Stroke in the young has not been thoroughly investigated with most previous studies based on a small number of patients from single centers. Furthermore, recent reports indicate that Fabry disease may be a significant cause for young stroke. The primary aim of our study was to determine the prevalence of Fabry disease in young strokepatients, while the secondary aim was to describe patterns of stroke in young patients. METHODS: We initiated the Stroke in Young Fabry Patients (sifap1) study as a multinational prospective European study of strokepatients aged 18-55 years and collected a broad range of clinical, laboratory, and radiological data using stringent standardized methods. All patients were tested for Fabry disease and blood was stored for future genetic testing. RESULTS: We managed to enroll 5,024 eligible young strokepatients in 15 countries and 47 centers across Europe between April 2007 and January 2010. The median number of patients included per center was 98 with a range between 8 and 315. The average duration of patient recruitment per center was 22 months, ranging between 5 and 33 months. The database was closed in July 2010. This paper describes protocol and methodology of the sifap1 study. CONCLUSION: The sifap1 study included the largest series of young strokepatients so far and will allow for analyses on a large number of aspects of stroke in the young.
Authors: Peter Kropp; Martin Holzhausen; Edwin Kolodny; Ulf Becker; Martin Dichgans; Exuperio Diez-Tejedor; Christian Enzinger; Franz Fazekas; Blanca Fuentes; Anna Karpinska; Wolfgang Meyer; Christian Tanislav; Tobias Böttcher; Arndt Rolfs Journal: J Neural Transm (Vienna) Date: 2013-06-09 Impact factor: 3.575
Authors: Tiina M Metso; Stéphanie Debette; Caspar Grond-Ginsbach; Stefan T Engelter; Didier Leys; Tobias Brandt; Alessandro Pezzini; Anna Bersano; Manja Kloss; Vincent Thijs; Philippe A Lyrer; Turgut Tatlisumak; Antti J Metso Journal: J Neurol Date: 2012-04-18 Impact factor: 4.849
Authors: Turgut Tatlisumak; Jukka Putaala; Markus Innilä; Christian Enzinger; Tiina M Metso; Sami Curtze; Bettina von Sarnowski; Alexandre Amaral-Silva; Gerhard Jan Jungehulsing; Christian Tanislav; Vincent Thijs; Arndt Rolfs; Bo Norrving; Franz Fazekas; Anu Suomalainen; Edwin H Kolodny Journal: J Neurol Date: 2015-11-14 Impact factor: 4.849
Authors: Christian Tanislav; Ulrike Grittner; Bjoern Misselwitz; Gerhard Jan Jungehuelsing; Christian Enzinger; Bettina von Sarnowski; Jukka Putaala; Manfred Kaps; Peter Kropp; Arndt Rolfs; Turgut Tatlisumak; Franz Fazekas; Edwin Kolodny; Bo Norrving Journal: BMC Neurol Date: 2014-03-07 Impact factor: 2.474
Authors: Manfred Kaps; Ulrike Grittner; Gerhard Jungehülsing; Turgut Tatlisumak; Christoph Kessler; Reinhold Schmidt; Putaala Jukka; Bo Norrving; Arndt Rolfs; Christian Tanislav Journal: BMJ Open Date: 2014-11-07 Impact factor: 2.692